Related Experiment Video

Updated: May 17, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell

Qingbing Meng1, Minqian Zheng, Hongbing Liu

  • 1Orthopedics Department, Yancheng City No. 1 People's Hospital, 16 Yue-He Road, Yancheng 224005, Jiangsu, People's Republic of China. ycmengqingbing@163.com

Molecular and Cellular Biochemistry
|October 31, 2012
PubMed

Insights

The SASH1 protein, a potential tumor suppressor, is significantly downregulated in osteosarcoma, correlating with increased metastasis and poorer prognosis. Overexpressing SASH1 inhibits osteosarcoma cell growth, invasion, and promotes apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • SASH1 (SAM and SH3 domain-containing protein 1) is a candidate tumor suppressor implicated in breast and colon cancers.
  • Reduced SASH1 expression is linked to tumor progression, invasion, metastasis, and poor patient outcomes.
  • The specific role of SASH1 in osteosarcoma pathogenesis remained largely unexplored.

Purpose of the Study:

  • To investigate the expression patterns of SASH1 in osteosarcoma tissues.
  • To correlate SASH1 expression with clinical-pathological features of osteosarcoma.
  • To elucidate the functional role of SASH1 in osteosarcoma cell behavior, including proliferation, apoptosis, and invasion.

Main Methods:

  • Quantitative analysis of SASH1 mRNA and protein expression in osteosarcoma tissues versus normal bone.
  • Correlation analysis between SASH1 expression levels and clinical parameters (metastasis, Enneking stage, gender, age, tumor size).
  • In vitro experiments using MG-63 osteosarcoma cells to assess the effects of SASH1 overexpression on cell viability, proliferation, apoptosis, and invasion, alongside Western blot analysis for key regulatory proteins (cyclin D1, caspase-3, MMP-9).

Main Results:

  • SASH1 mRNA and protein expression were significantly downregulated in osteosarcoma tissues compared to normal bone.
  • Lower SASH1 expression correlated with lung metastasis and advanced Enneking stage, but not with gender, age, or tumor size.
  • Overexpression of SASH1 in MG-63 cells led to reduced cell viability, proliferation, and invasion, increased apoptosis, and altered expression of cyclin D1, caspase-3, and MMP-9.

Conclusions:

  • SASH1 functions as a tumor suppressor in osteosarcoma.
  • Downregulation of SASH1 is associated with aggressive osteosarcoma phenotypes and poor prognosis.
  • SASH1 overexpression exhibits anti-tumor effects by inhibiting proliferation and invasion while promoting apoptosis in osteosarcoma cells.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...